Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Ibrutinib and Venetoclax for First-Line Treatment of CLL

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A More COMPLETE Picture of Revascularization in STEMI

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Partial Oral Therapy for Osteomyelitis and Endocarditis. Reply

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Effects of Serelaxin in Patients with Acute Heart Failure

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Epidemiology of bloodstream infections in patients with chronic lymphocytic leukemia: a longitudinal nation-wide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Original languageEnglish
JournalThe New England journal of medicine
Volume381
Issue number8
Pages (from-to)788-789
Number of pages2
ISSN0028-4793
DOIs
Publication statusPublished - 22 Aug 2019

    Research areas

  • Bridged Bicyclo Compounds, Heterocyclic, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Pyrazoles, Pyrimidines, Sulfonamides

ID: 58442118